Accessibility Tools

Musculoskeletal Infection Society – North America24thAnnual Open Scientific MeetingAugust 8 & 9, 2014Francis Drake Hotel, Charleston, SC Agenda

Friday – August 8, 2014

7:15 a.m.
Registration Open
7:15 – 8:00 a.m.
Charleston, SC
8:00–8:05 a.m.
Welcome, Announcements, Disclosure – Camelia Marculescu, MD

Clinical Science Presentations Session 1 – Abinash Virk, MD, Moderator

8:06–8:12 a.m.
(18)F–FDG And (68)Ga–Citrate PET/CT Imaging May Mimic Periprosthetic Joint Infection (PJI) in Mom Patients with Moderate to Severe ARMD – Hannu T. Aro, MD
8:13–8:19 a.m.
Management of Psoas Muscle Abscess Associated with Skeletal Infections – Maja Babic, MD
8:20–8:26 a.m.
Previous Periprosthetic Joint Infection Predicts Infection after New Primary Arthroplasty – Gregory Deirmengian, MD
8:27–8:33 a.m.
Effectiveness of a Decolonization Program in Eradication of MRSA in Patients Undergoing Elective Total Joint Arthroplasty Bryan D. Springer, MD
8:34–8:40 a.m.
Outcome of Patients with Prosthetic Joint Infection, a Prospective Two Site Cohort Study: The Mayo Clinic, Rochester, MN and the Endo Klinik, Hamburg Germany – Elie F. Berbari, MD
8:41–8:51 a.m.
Discussion
8:52–8:58 a.m.
Patients with Abnormal Infection Parameters need to be Investigated Prior to Revision Arthroplasty – Speaker TBD
8:59–9:05 a.m.
Utility of Synovial White Cell Count and Neutrophil Differential during Reimplantation Surgery – Corey Clyde, MD
9:06–9:12 a.m.
Dual Antibiotic Prophylaxis is Associated with Acute Kidney Injury after Primary Joint Arthroplasty – P. Maxwell Courtney, MD
9:13–9:19 a.m.
Outcomes in TKA Complicated by Infection: A Matched Cohort Design – Ivan Dzaja, MD
9:20–9:26 a.m.
Comparison of Gown Contamination in Simulated Total Joint Surgery James Fraser, MD
9:27–9:33 a.m.
Gender Associated Disparities in Comorbidity: A Cause for PJI Elie Ghanem, MD
9:34–9:44 a.m.
Discussion
9:45–10:10 a.m.
Refreshment Break
Visit Corporate Partners, View Electronic Posters
10:11–10:17 a.m.
Minocycline–Induced Cutaneous Hyperpigmentation in an Orthopedic Patient Population – Yuri Hanada, MD
10:18–10:24 a.m.
Minocycline as Long Term Suppressive Therapy for Orthopedic Infections – Yuri Hanada, MD
10:25–10:31 a.m.
Enhanced Detection of Staphylococcus aureus Colonization in Patients Undergoing Total Joint Arthroplasty – Tyler White, BS
10:32–10:38 a.m.
Supra–Acetabular Cemented Roof Spacer to Improve Hip Stability in 1st Stage Infected THA – Surgical Technique and Results Kevin Koo, MD
10:39–10:45 a.m.
The Results of Partial Retention, Limited Debridement, and Immediate Limited Exchange in the Treatment of Newly Infected Total Joints – Gerhard E. Maale, MD
10:46–10:56 a.m.
Discussion

Basic Science Presentations Session 1 – Alex McLaren, MD, Moderator

10:57–11:03 a.m.
Locally Delivered Liposomal Amphotericin B Loaded Bone Cement is Not Cytotoxic in Vivo – Josh Bingham, MD
11:04–11:10 a.m.
Organisms Causing PJI Stimulate Synovial Fluid Alpha–Defensin Carl Deirmengian, MD
11:11 a.m.–11:17 p.m.
Gentamicin Elution from Prefabricated Articulating Spacers is Uniform among Sites – Oren Goltzer, MD
11:18–11:24 a.m.
Preliminary Results for Local Stimuli Responsive Drug Delivery Composite: Chitosan Sponge Augmented with Chitosan Microspheres Containing Fe3O4 Nanoparticles – Alex Hoban
11:15–11:21 a.m.
Functional Evaluation of Local Delivery of Amphotericin B and Vancomycin from Modified for Biofilm Inhibition Amber Jennings, PhD
11:22–11:28 p.m.
Novel Antibiotic–Loaded Point–of–Care Implant Coating Inhibits Biofilm – Amber Jennings, PhD
11:29–11:39 p.m.
Discussion
11:40 a.m.–12:30 p.m.
Symposium: Challenges in the Diagnosis and Management of Orthopedic Infections – Focus on the Immunocompromised Host Harry Demos, MD, Lee Leddy, MD, Douglas R. Osmon, MD
12:30–1:30 p.m.
Luncheon

Basic Science Presentations Session 2 – Carl Deirmengian, MD, Moderator

1:35–1:41 p.m.
Extended Antibiotic Elution and Concomitant Bone Remodeling by an Injectable Bone Graft Substitute Impregnated with Gentamicin B. Fedrick Lindberg, MD
1:42–1:48 p.m.
Sonication Is Not Useful in Clinically Infected Trauma Explants Nathaniel C. Wingert, MD
1:49–1:55 p.m.
Pre–Admission Chlorhexidine Preparation Reduces Surgical Site Infections Following Lower Extremity Total Joint Arthroplasty Michael A. Mont, MD
1:56–2:02 p.m.
The Effect of a Novel Marine Nuclease on the Removal of Biofilm: A New Approach to Periprosthetic Infection – Martin Marsh, MD
2:03–2:09 p.m.
Demonstration of the Ability of a CHG Incise Drape to Reduce Bacterial Contamination of Surgical Wounds in a Porcine Surgery Model – Linda Olson
2:10–2:20 p.m.
Discussion
2:21–2:45 p.m.
Refreshment Break
Visit Corporate Partners, View Electronic Posters
2:46–2:52 p.m.
In Vivo Biofilm Infection Prevention using Local Drug Delivery via Biocompatible Chitosan Paste – Cheyenne S. Rhodes, MD
2:53–2:59 p.m.
Liposomal Amphotericin B is Less Toxic than Amphotericin B Deoxycholate in Vitro – Justin Roberts, MD
3:00–3:06 p.m.
Premature Antibiotic Treatment can potentially Compromise the Diagnosis of PJI – Ali Sina Shahi, MD
3:14–3:20 p.m.
Lower Bacterial Load with Prophylactic Regional Intraosseous Antibiotics in Murine Model of Total Knee Arthroplasty Timothy Roberts, MD
3:20–3:30 p.m.
Discussion
4:45–5:00 p.m.
Announcements, Adjourn
6:00–8:00 p.m.
President’s Reception
Palmetto Garden Room and Courtyard
Belmond Charleston Place

Saturday – August 9, 2014

7:30 a.m.
Registration Opens
7:45–8:45 a.m.
Breakfast – Visit Corporate Partners, View Electronic Poster
8:00–8:30 a.m.
Business Meeting – MSIS Members Only
8:30–8:35 a.m.
Welcome, Announcements, Disclosure – Camelia Marculescu, MD
8:36–9:35 a.m.
Presidential Guest Lecture
State–of–the–art in Prosthetic Joint Infections: Current Concepts in
Diagnosis and Management
Dr. Werner Zimmerli

Clinical Science Presentations Session 2 – Steven Schmitt, MD, Moderator

9:36–9:42 a.m.
Comparison of the 2011 Musculoskeletal Infection Society (MSIS), the 2013 International Consensus Meeting (ICM) and the Infectious Diseases Society of America (IDSA) Diagnostic Criteria for Prosthetic Joint Infection (PJI) – Dante P. Melendez Lecca, MB, ChB
9:43–9:49 a.m.
The Economic Impact of Periprosthetic Infections Following Total Hip Arthroplasty at a Specialized Tertiary–Care Center Michael A. Mont, MD
9:50–9:56 a.m.
Periprosthetic Shoulder Infection in the United States: Incidence and Economic Burden – Surena Namdari, MD
9:57–10:03 a.m.
A Functional Antibiotic Spacer Provides Patients with Similarly Satisfying Options of One or Two Stage Treatment for Chronic Periprosthetic Infection – Dr. Aidin Eslam Pour
10:04–10:10 a.m.
The Limited Utility of Nucleated Cell Counts for the Diagnosis of Infection in the Setting of Periprosthetic Fracture Stephen Preston, MD
10:10–10:20 a.m.
Discussion
10:20–10:45 a.m.
Refreshment Break
Visit Corporate Partners, View Electronic Posters
10:46–10:52 a.m.
Complications in Underweight Total Knee Arthroplasty Patients Antonia Chen, MD
10:53–10:59 a.m.
Delaying Reimplantation Following Resection Arthroplasty Does Not Improve Outcomes: A Report from Two High Volume Orthopaedic Centers – Anthony Tokarski, MD
11:00–11:06 a.m.
Mid–Term Survivorship and Outcomes of Two–Stage Revisions for Infected Total Hip Arthroplasty – Edward Vasarhelyi, MD
11:07–11:13 a.m.
A New National Surgical Site Infection Improvement Program for New Zealand: Project and Results – Kelly Vince, MD
11:14–11:24 a.m.
Discussion
11:25–11:31 a.m.
Prosthetic Joint Infection due to Salmonella Species: A Case Series Abinash Virk, MD
11:32–11:38 a.m.
Method of Tissue Sampling may have an Effect on Contamination Risk Antonia Chen, MD
11:39–11:45 a.m.
Surgical Case Order in Total Joint Arthroplasty has No Effect on Infection Risk – Antonia Chen, MD
11:46–11:52 a.m.
The Incidence of Periprosthetic Joint Infection after Aseptic Index Knee Revision Surgery – Paul McLendon, MD
11:53 a.m.–12:05 p.m.
Discussion
12:05–12:15 p.m.
Announcements, Adjourn
Musculoskeletal Infecton Society
Musculoskeletal Infecton Society
P.O. Box 422
Rochester, MN 55903-0422
info@msis-na.org